Stay Informed About Key Developments for Our Company

The Latest Updates as They Happen

Explore All
March 29, 2020
Not intended for U.S. and UK Media - New study results add to solid evidence for the efficacy and safety of Rivaroxaban in the prevention of venous thromboembolism:
March 28, 2020
Not intended for U.S. and UK Media - Data from Phase III VOYAGER PAD study published in The New England Journal of Medicine and presented during the American College of Cardiology’s 69th Annual Scientific Session together with World Congress of Cardiology (ACC.20/WCC Virtual)
March 28, 2020
Not intended for U.S. and UK Media - Data from Phase III VICTORIA study presented at American College of Cardiology’s 69th Annual Scientific Session Together With World Congress of Cardiology (ACC.20/WCC)
March 20, 2020
Not intended for U.S. and UK Media - American College of Cardiology’s 69th Annual Scientific Session together with World Congress of Cardiology (ACC.20/WCC Virtual):
February 26, 2020
Personnel changes after Annual Stockholders' Meeting on April 28, 2020: